<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; HPV</title>
	<atom:link href="http://www.canadiannetmall.com/blog/tag/hpv/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.canadiannetmall.com/blog</link>
	<description></description>
	<lastBuildDate>Sat, 07 May 2011 13:51:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Preventing Genital Warts With Gardasil in Males</title>
		<link>http://www.canadiannetmall.com/blog/preventing-genital-warts-with-gardasil-in-males/</link>
		<comments>http://www.canadiannetmall.com/blog/preventing-genital-warts-with-gardasil-in-males/#comments</comments>
		<pubDate>Wed, 09 Dec 2009 15:33:32 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Women's health]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[Gardasil vaccine]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[papillomavirus]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=2545</guid>
		<description><![CDATA[Merck&#8217;s Gardasil vaccine is now indicated for the prevention of genital warts (condyloma acuminata) caused by human papillomavirus (HPV) types 6 and 11 in boys and men 9 through 26 years of age. Gardasil is currently approved for use in girls and women 9 through 26 years of age for preventing cervical, vulvar, and vaginal [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/preventing-genital-warts-with-gardasil-in-males/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Folotyn and Peripheral T-Cell Lymphoma</title>
		<link>http://www.canadiannetmall.com/blog/folotyn-and-peripheral-t-cell-lymphoma/</link>
		<comments>http://www.canadiannetmall.com/blog/folotyn-and-peripheral-t-cell-lymphoma/#comments</comments>
		<pubDate>Wed, 21 Oct 2009 16:59:33 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Drugs News]]></category>
		<category><![CDATA[Folotyn]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[Pralatrexate Folotyn  Allos]]></category>
		<category><![CDATA[PTCL]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=2533</guid>
		<description><![CDATA[Pralatrexate (Folotyn, Allos) has been approved as the first agent to treat peripheral T-cell lymphoma (PTCL), often an aggressive type of non-Hodgkin&#8217;s lymphoma. Pralatrexate was designated as an orphan drug under the agency&#8217;s accelerated approval process. The approval was based on evidence that it reduced tumor size, as shown on imaging scans in one study. [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/folotyn-and-peripheral-t-cell-lymphoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

